Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Spero Therapeutics, Inc. (SPRO) vs Tenax Therapeutics, Inc. (TENX)

Spero Therapeutics, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Spero Therapeutics, Inc. and Tenax Therapeutics, Inc. are of similar size ($71.6M and $70.0M). Tenax Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Spero Therapeutics, Inc. trades at 8.8×. Spero Therapeutics, Inc. grew revenue faster over the last twelve months: 37.2% against −70.8%. Across the 14 metrics below, Spero Therapeutics, Inc. leads on 10 and Tenax Therapeutics, Inc. on 4.

Valuation

Metric SPRO TENX Biotechnology median
P/E 8.79 n/m 7.88
P/S 1.17 267.65 11.47
P/B 1.61 0.81 2.52
Price to free cash flow 3.65 n/m 21.16
EV/EBITDA 3.41 0.38 0.74
EV/Sales 0.34 (75.11) 10.73
Earnings yield 11.38% (81.77%) (28.84%)
Free cash flow yield 27.41% (50.03%) (23.03%)

Profitability

Metric SPRO TENX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 19.17% (59.80%) (57.72%)
Return on assets 12.85% (57.02%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SPRO TENX Biotechnology median
Revenue growth (TTM) 37.24% (70.77%) 5.64%
EPS growth (last fiscal year) 111.81% (16.52%) —
Revenue growth, 5-year CAGR 48.25% 0.79% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SPRO TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.12 15.07 4.73
Net debt to EBITDA (6.38) 1.73 0.96

Dividend

Metric SPRO TENX Biotechnology median
Dividend yield — 3.39% 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric SPRO TENX Biotechnology median
Market cap 71.63m 69.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack